Document Detail


Butaclamol hydrochloride in newly admitted schizophrenics.
MedLine Citation:
PMID:  778939     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Butaclamol hydrochloride, a new type of antipsychotic drug, was evaluated by an uncontrolled study of 13 newly admitted schizophrenic patients. The drug had antipsychotic effects as well as a strong propensity for evoking extrapyramidal side effects. With the maximal daily doses of 30 mg used in this study, therapeutic results obtained were probably somewhat less than optimal.
Authors:
L E Hollister; K L Davis; P A Berger
Related Documents :
18471899 - Antipsychotic drug action: antagonism, inverse agonism or partial agonism.
2883679 - Clinical experience with the neuroleptic zotepine--first results.
16421629 - Role of central glutamatergic neurotransmission in the pathogenesis of psychiatric and ...
12728409 - Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?
11741099 - Efficacy of cabergoline in long-term use: results of three observational studies in 1,5...
6996079 - Biochemical processes in schizophrenia: an update.
9742549 - Transdermal permeation modulation by cyclodextrins: a mechanistic study.
2260219 - Problems of drug therapy of epilepsy in developing countries.
18337209 - Effect of core and surface cross-linking on the entrapment of metronidazole in pectin b...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Psychopharmacology communications     Volume:  1     ISSN:  0098-616X     ISO Abbreviation:  Psychopharmacol Commun     Publication Date:  1975  
Date Detail:
Created Date:  1976-09-01     Completed Date:  1976-09-01     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7508718     Medline TA:  Psychopharmacol Commun     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  493-500     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Trials as Topic
Dibenzocycloheptenes / adverse effects,  therapeutic use*
Humans
Male
Psychiatric Status Rating Scales
Schizophrenia / drug therapy*
Time Factors
Chemical
Reg. No./Substance:
0/Dibenzocycloheptenes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  On cats and the territorial imperative.
Next Document:  Vision in fish. An historical and analytical bibliography